A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus
about
Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawalManagement of patients with hepatitis B in special populationsIs mother-to-infant transmission the most important factor for persistent HBV infection?Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital.Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis.Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.Individualized management of pregnant women with high hepatitis B virus DNA levels.Prevention of Perinatal Hepatitis B Virus Transmission.Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.AASLD guidelines for treatment of chronic hepatitis B.Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis.Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials.[Prevention of mother to child transmission of hepatitis B].Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.A Spotty Liver of PregnancyOptimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is PregnantCost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral loadSafety of lamivudine treatment for chronic hepatitis B in early pregnancy.Hepatitis B and C in pregnancy: a review and recommendations for care.Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus.HBV perinatal transmissionLiver diseases in pregnancy: diseases not unique to pregnancy.Hepatitis B virus infection and pregnancy: a practical approach.Optimal management of HBV infection during pregnancy.Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis.Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: the evidence, current practice and future challenges.Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Hepatitis B virus infection in children.Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders.Prophylaxis of vertical HBV infection.Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women.Controversy and Strategies Exploration in Blocking Mother-to-Child Transmission of Hepatitis B.Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads.Prevention of mother-to-child transmission of hepatitis B virus (HBV) during pregnancy and the puerperium: current standards of care.
P2860
Q26995814-A4E71D8E-81C3-4E20-9685-54AC748DADF5Q27016136-DA4FA131-3E62-438D-B80D-FFA7775553D3Q28083160-90CA5807-A4AE-4336-BD4A-C2284D751D24Q30391932-E76B7000-E628-421A-8B62-FFDBACB380E5Q33606219-353344B1-C654-4AE4-98DF-6C4DA736D0D8Q33639600-6F67D893-D204-4B84-A712-FA2845DFD610Q33805272-7CD6793C-771F-4FA2-A98F-D885940943BDQ33829957-B2997BB0-F984-4713-AF32-57C7E5557FBAQ34168470-3516A7BD-3047-4841-B2B3-48765338B12AQ34181732-C492A30E-4011-4757-8362-0F6A22E6017CQ34371989-C0F7803F-E4AB-460C-A930-C308F9EE1D94Q34501660-748768F9-C231-491C-9BAF-1B6350E692B6Q34657327-76E4ED49-5353-4D9F-AD36-F5F2418BA1BCQ35196581-62C698E9-8E50-4193-BBA1-1FDADA6CF8A2Q35817655-3F18A90F-54AB-46D7-85E2-F226B09276B1Q35840548-A2BED917-9D16-4CBC-96FD-C0C412008B4FQ35927698-16509997-D92E-49D5-94F1-A48DF34BD466Q35999165-F74EDA9E-F039-4802-8EB8-CDC70486CABDQ36379986-61280916-67C9-4EB7-BA99-1FA09E7B3B27Q36452141-FEC7A9D8-EC03-4C56-A4CC-D72B70912C61Q36649138-4A201213-C96E-46AF-83B0-FBE2D0F211C3Q36738003-2F5668DE-4DFE-4A45-ACF5-4503BB72B940Q36860696-8C3F3319-7DF0-4227-B282-E80161EBC526Q37334112-3CC978FD-52E3-4389-A6D6-172315421302Q38004993-9672BF5B-470D-44DF-A7DA-757B395A2899Q38071406-6E5BB751-31F8-487D-BE4E-93011DABC0EFQ38160176-9CCCC9EB-E876-494B-B618-AE3041FD3EE5Q38211738-61D4F43C-617D-4BA5-A6F4-3444E242EC08Q38217668-E914404E-3D3B-45C5-A294-98BFCE989B35Q38240691-C91E78DA-2F22-426C-852D-2FE4EDB4E2FAQ38293584-04892DA7-0D46-4FF7-B39D-A5DE55DA32CBQ38365905-9060B623-9CF1-4CD8-9C0A-849036401263Q38609568-ECF9F7CE-E162-409A-AE9C-7BDEA350ABA5Q38893286-A3D3FF87-22A9-4751-B855-8E8C33A5E192Q39256818-AB36633C-1186-44D0-A6C4-0227BEB613E5Q39258357-D744ABB4-44F8-416A-91E7-70BEE5C0E69DQ40540669-3578D7B4-7E46-4065-800B-8049906FBF41Q40697007-CAF2A5AE-FA69-4406-9027-3738A45195D1Q41670611-6C88EDD5-51B6-456C-AE98-056F0187CDB9Q42272863-8F4F5690-92A1-4B05-A54A-F4D68832717A
P2860
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@ast
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@en
type
label
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@ast
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@en
prefLabel
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@ast
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@en
P2093
P2860
P356
P1476
A meta-analysis of lamivudine ...... nsmission of hepatitis B virus
@en
P2093
Guang-Wen Cao
Hong-Wei Zhang
Hong-Yang Wang
Jia-Xin Xie
P2860
P304
P356
10.3748/WJG.V17.I38.4321
P407
P577
2011-10-01T00:00:00Z